These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 2848467)

  • 1. [The action of combinations of the nonapeptide polymyxin B with antibiotics on gram-negative bacteria].
    Bairamashvili DI; Zinchenko AA; Maslin DN; Trakhanova MN; Miroshnikov AI
    Antibiot Khimioter; 1988 Aug; 33(8):591-4. PubMed ID: 2848467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of gram-negative bacteria to polymyxin B nonapeptide.
    Viljanen P; Vaara M
    Antimicrob Agents Chemother; 1984 Jun; 25(6):701-5. PubMed ID: 6331296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of polymyxin B and the novel polymyxin analogue CB-182,804 against contemporary Gram-negative pathogens in New York City.
    Quale J; Shah N; Kelly P; Babu E; Backer M; Rosas-Garcia G; Salamera J; George A; Bratu S; Landman D
    Microb Drug Resist; 2012 Apr; 18(2):132-6. PubMed ID: 22196342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymyxin B nonapeptide potentiates the eradication of Gram-negative bacterial persisters.
    Kim SJ; Jo J; Kim J; Ko KS; Lee W
    Microbiol Spectr; 2024 Apr; 12(4):e0368723. PubMed ID: 38391225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane-disorganizing property of polymyxin B nonapeptide.
    Lam C; Hildebrandt J; Schütze E; Wenzel AF
    J Antimicrob Chemother; 1986 Jul; 18(1):9-15. PubMed ID: 3019982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymyxin Derivatives that Sensitize Gram-Negative Bacteria to Other Antibiotics.
    Vaara M
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30641878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent synergy and sustained bactericidal activity of polymyxins combined with Gram-positive only class of antibiotics versus four Gram-negative bacteria.
    Wang Y; Feng J; Yu J; Wen L; Chen L; An H; Xiao W; Zhang B; Feng H; Zhou M; Jiang Z
    Ann Clin Microbiol Antimicrob; 2024 Jul; 23(1):60. PubMed ID: 38965559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial synergism of polymyxin B nonapeptide and hydrophobic antibiotics in experimental gram-negative infections in mice.
    Ofek I; Cohen S; Rahmani R; Kabha K; Tamarkin D; Herzig Y; Rubinstein E
    Antimicrob Agents Chemother; 1994 Feb; 38(2):374-7. PubMed ID: 8192470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic Antimicrobial Activity Between the Broad Spectrum Bacteriocin Garvicin KS and Nisin, Farnesol and Polymyxin B Against Gram-Positive and Gram-Negative Bacteria.
    Chi H; Holo H
    Curr Microbiol; 2018 Mar; 75(3):272-277. PubMed ID: 29058043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of gram-negative bacteria to the synergistic bactericidal action of serum and polymyxin B nonapeptide.
    Viljanen P; Käyhty H; Vaara M; Vaara T
    Can J Microbiol; 1986 Jan; 32(1):66-9. PubMed ID: 3008971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of Antibiotic Activity by a Novel Cationic Peptide: Potency and Spectrum of Activity of SPR741.
    Corbett D; Wise A; Langley T; Skinner K; Trimby E; Birchall S; Dorali A; Sandiford S; Williams J; Warn P; Vaara M; Lister T
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical translation of polymyxin-based combination therapy: Facts, challenges and future opportunities.
    Zhang X; Guo F; Shao H; Zheng X
    J Infect; 2017 Feb; 74(2):118-130. PubMed ID: 27998750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of dilipid polymyxins: Investigation on the effect of hydrophobicity through its fatty acyl component.
    Domalaon R; Berry L; Tays Q; Zhanel GG; Schweizer F
    Bioorg Chem; 2018 Oct; 80():639-648. PubMed ID: 30053708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial Susceptibility Testing for Polymyxins: Challenges, Issues, and Recommendations.
    Ezadi F; Ardebili A; Mirnejad R
    J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30541939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymyxin B in Combination with Enrofloxacin Exerts Synergistic Killing against Extensively Drug-Resistant Pseudomonas aeruginosa.
    Lin YW; Yu HH; Zhao J; Han ML; Zhu Y; Akter J; Wickremasinghe H; Walpola H; Wirth V; Rao GG; Forrest A; Velkov T; Li J
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion of antibacterial spectrum of xanthorrhizol against Gram-negatives in combination with PMBN and food-grade antimicrobials.
    Kim MS; Kim HR; Kim H; Choi SK; Kim CH; Hwang JK; Park SH
    J Microbiol; 2019 May; 57(5):405-412. PubMed ID: 30796747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria.
    Vaara M; Porro M
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1801-5. PubMed ID: 8843284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymyxin derivatives: a patent evaluation (WO2012168820).
    Wu H; Teng P; Niu Y; Li Q; Cai J
    Expert Opin Ther Pat; 2013 Aug; 23(8):1075-81. PubMed ID: 23806121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents.
    Vaara M; Fox J; Loidl G; Siikanen O; Apajalahti J; Hansen F; Frimodt-Møller N; Nagai J; Takano M; Vaara T
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3229-36. PubMed ID: 18591267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro cytotoxicity and antibiotic activity of polymyxin B nonapeptide.
    Duwe AK; Rupar CA; Horsman GB; Vas SI
    Antimicrob Agents Chemother; 1986 Aug; 30(2):340-1. PubMed ID: 3021053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.